Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-069994

EVP, Research & CSO sold 4,125 shares at an average $48.63 ($200,585)

  • EVP, Research & CSO acquired 4,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-14 Exercise or conversion : show line 1 in the form +1,375 $1.53 $2,104 109,075 D
2021-12-14 Sale : show line 2 in the form −1,375 $45.88 $63,085 107,700 D
2021-12-15 Exercise or conversion : show line 3 in the form +2,750 $1.53 $4,208 110,450 D
2021-12-15 Sale : show line 4 in the form −2,750 $50.00 $137,500 107,700 D
Open-market sales · 4,125 sh · avg $48.63 · $200,585

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-12-14 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,375 229,130 D
2021-12-15 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,750 226,380 D
Loading xslF345X03/doc4.xml…